Another Psychedelics Company Goes Public: Albert Labs To List On CSE, Appoints Chrystal Capital As UK Banker
Another Psychedelics Company Goes Public: Albert Labs To List On CSE, Appoints Chrystal Capital As UK Banker
Psychedelic-based medicines company Albert Labs is going public.
迷幻藥業公司阿爾伯特實驗室即將公之於眾。
On Monday, management said it has received conditional approval for the listing of its common shares on the Canadian Securities Exchange (CSE). The stock is expected to start trading under the ticker "ABRT" in early 2022, following a reverse takeover (RTO) of ME Resource Corp.
週一，管理層表示，其普通股在紐約證交所上市已獲得有條件的批准。加拿大證券交易所(CSE)。在反向收購(RTO)之後，該股預計將於2022年初開始交易，股票代碼為“ABRT”。我的資源公司(ME Resource Corp.)
"Conditional approval on the Canadian Securities Exchange represents a significant milestone for Albert Labs as we gear up to become a public company," said Dr. Michael Raymont, CEO of Albert Labs. "Listing on the CSE will enable us to attract additional capital and enhance our market profile, which in turn will catalyze our growth toward becoming a worldwide leader and provider of accelerated access to psychotherapeutic medicines and therapies."
他説：“加拿大證券交易所(Canada Securities Exchange)的有條件批准對阿爾伯特實驗室來説是一個重要的里程碑，因為我們正準備成為一家上市公司。”邁克爾·雷蒙特博士艾伯特實驗室的首席執行官。在CSE上市將使我們能夠吸引更多資本，提高我們的市場形象，這反過來將促進我們成長為加速獲得精神治療藥物和治療的全球領先者和供應商。“
A New Banker
一位新銀行家
In addition to the listing, Albert Labs confirmed the appointment of Chrystal Capital Partners LLP to act as its European Capital Markets advisor.
除了上市，艾伯特實驗室確認任命Chrystore Capital Partners LLP擔任其歐洲資本市場顧問。
In this capacity, Chrystal Capital will advise Albert Labs on proposed plans to undertake a London Stock Exchange dual listing.
以這一身份，Chrystore Capital將就擬議的計劃向Albert Labs提供建議，以進行倫敦證券交易所兩地上市.
Kingsley Wilson, founding partner of Chrystal Capital Partners stressed his belief in the benefits of psychedelic medicines.
金斯利·威爾遜，創始合夥人克里斯特爾資本合夥公司強調他相信迷幻藥的好處。
"We believe that psychedelic medicines will have a critical and profound effect for millions of people suffering and we have been patiently looking for the right company and team to back. To that end, we are delighted to have found such a business in Albert Labs as they look to grow into Europe," Wilson said. "The Albert Labs' team have a great passion and a refreshingly unique approach to the industry which we believe will bring urgently needed solutions to patients and simultaneously create significant shareholder value for our investors. Chrystal Capital will work closely with the Albert Labs' management team to strategize beyond the concurrent CSE listing, assisting Albert Labs to execute on their fundraising goals and their plan to dual list in the UK".
威爾遜説：“我們相信迷幻藥物將對數百萬遭受痛苦的人產生關鍵而深遠的影響，我們一直在耐心地尋找合適的公司和團隊來支持。為此，我們很高興在阿爾伯特實驗室找到這樣的業務，因為他們希望進入歐洲。”阿爾伯特實驗室的團隊對該行業有着巨大的熱情和令人耳目一新的獨特方法，我們相信這將為患者帶來迫切需要的解決方案，同時為我們的投資者創造巨大的股東價值。克里斯特爾資本公司將與阿爾伯特實驗室的管理團隊密切合作，制定超越同時在CSE上市的戰略，協助阿爾伯特實驗室執行他們的籌資目標和在英國兩地上市的計劃。“
Más contenido sobre cannabis en Español en El Planteo.
Más爭辯説，大麻在西班牙和El Planteo都是可悲的。
譯文內容由第三人軟體翻譯。